Publications
- 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment2015 | Publication without faculty affiliation
- Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition2024 | First Faculty of Medicine, Faculty of Science, Third Faculty of Medicine
- In silico library screening to find novel anticancer agent with chemosensitizing properties: focus on targeting ataxia telangiectasia and Rad3 related kinase2024 | Faculty of Medicine in Hradec Králové
- Differentiated SH-SY5Y neuroblastoma cells as a model for evaluation of nerve agent-associated neurotoxicity2023 | First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- Structure-Guided Design of N-Methylpropargylamino- Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer's Disease2023 | Faculty of Pharmacy in Hradec Králové, Faculty of Science
- Pyrimidine derivatives with antitubercular activity2023 | Faculty of Pharmacy in Hradec Králové
- UHPLC-Orbitrap study of the first phase tacrine in vitro metabolites and related Alzheimer's drug candidates using human liver microsomes2023 | Faculty of Pharmacy in Hradec Králové
- 2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE12023 | Faculty of Pharmacy in Hradec Králové
- A-agents, misleadingly known as "Novichoks": a narrative review2023 | Faculty of Pharmacy in Hradec Králové
- Tacrine First-Phase Biotransformation and Associated Hepatotoxicity: A Possible Way to Avoid Quinone Methide Formation2023 | Faculty of Pharmacy in Hradec Králové
Loading network view...